Advertisement

Sarcopenia and health-related outcomes: an umbrella review of observational studies

  • Nicola VeroneseEmail author
  • Jacopo Demurtas
  • Pinar Soysal
  • Lee Smith
  • Gabriel Torbahn
  • Daniel Schoene
  • Lukas Schwingshackl
  • Cornel Sieber
  • Jurgen Bauer
  • Matteo Cesari
  • Oliviere Bruyere
  • Jean-Yves Reginster
  • Charlotte Beaudart
  • Alfonso J. Cruz-Jentoft
  • Cyrus Cooper
  • Mirko Petrovic
  • Stefania Maggi
  • the Special Interest Groups in Systematic Reviews and Meta-analyses for healthy ageing Sarcopenia and Frailty and resilience in older persons of the European Geriatric Medicine Society (EuGMS)
Review

Key summary points

Aim

To investigate associations of sarcopenia with adverse health-related outcomes, through an umbrella review method.

Findings

Sarcopenia appears to be significantly associated with several adverse outcomes in older people, with a strong evidence for increased risk of mortality, disability, and falls.

Message

Sarcopenia is associated with several adverse health-related outcomes in older people, indicating the need of assessing this condition in daily practice.

Abstract

Background

The clinical relevance of sarcopenia has increasingly been recognized. However, whether it is associated with the development of other medical conditions is still unclear. Therefore, we aimed to capture the scale of outcomes that have been associated with the presence of sarcopenia and systematically assess the quality, strength, and credibility of these associations using an umbrella review methodology.

Methods

A systematic review in several databases was carried out, until 20th February 2019. For each association, random-effects summary effect size, 95% confidence intervals (CIs), heterogeneity (I2), evidence for small-study effect, evidence for excess significance bias, and 95%-prediction intervals were estimated. We used these metrics to categorize the evidence of significant outcomes (p < 0.05) from class I (convincing) to class IV (weak), according to pre-established criteria.

Results

From 358 abstracts, 6 meta-analyses with 14 associations were included. Sarcopenia was associated with higher risk of other comorbidities and mortality in 11 of 14 outcomes explored. However, only 3 outcomes (i.e., association between sarcopenia and increased risk of death in community-dwelling older people [odds ratio, OR = 3.60; 95% CI 2.96–4.37; n = 14,305], disability [OR = 3.04; 95% CI 1.80–5.12; n = 8569], and falls [OR = 1.60; 95% CI 1.31–1.97; n = 12,261]) presented a highly suggestive evidence (class II). Other association was classified as having only a weak evidence.

Conclusion

Sarcopenia is associated with several adverse health-related outcomes in older people, and its associations with mortality, disability, and falls are supported by a highly suggestive evidence. The effect of interventions on sarcopenia to improve these outcomes needs to be investigated.

Keywords

Sarcopenia Health Umbrella review Meta-analysis Mortality Fall Disability Risk factor 

Notes

Compliance with ethical standards

Conflict of interest

All authors declare no conflict of interest.

Ethical approval

It was not requested being a revision of already published literature.

Informed consent

No patients were included in this review.

Sponsor’s role

None.

Supplementary material

41999_2019_233_MOESM1_ESM.docx (32 kb)
Supplementary material 1 (DOCX 32 kb)

References

  1. 1.
    Sarcopenia Woo J (2017) Clin Geriatr Med 33(3):305–314Google Scholar
  2. 2.
    Landi F, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E et al (2012) Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr 31(5):652–658.  https://doi.org/10.1016/j.clnu.2012.02.007 Google Scholar
  3. 3.
    Cederholm T, Cruz-Jentoft AJ, Maggi S (2013) Sarcopenia and fragility fractures. Eur J Phys Rehabil Med 49(1):111–117Google Scholar
  4. 4.
    Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, Harris TB (2010) Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 21(4):543–559.  https://doi.org/10.1007/s00198-009-1059-y Google Scholar
  5. 5.
    Cesari M, Pahor M, Lauretani F, Zamboni V, Bandinelli S, Bernabei R et al (2009) Skeletal muscle and mortality results from the InCHIANTI Study. J Gerontol Ser A Biol Sci Med Sci 64(3):377–384.  https://doi.org/10.1093/gerona/gln031 Google Scholar
  6. 6.
    Gariballa S, Alessa A (2013) Sarcopenia: prevalence and prognostic significance in hospitalized patients. Clin Nutr (Edinb Scotl) 32(5):772–776.  https://doi.org/10.1016/j.clnu.2013.01.010 Google Scholar
  7. 7.
    Perkisas S, De Cock A-M, Vandewoude M, Verhoeven V (2018) Prevalence of sarcopenia and 9-year mortality in nursing home residents. Aging Clin Exp Res 31(7):951–959Google Scholar
  8. 8.
    Rizzoli R, Reginster JY, Arnal JF, Bautmans I, Beaudart C, Bischoff-Ferrari H et al (2013) Quality of life in sarcopenia and frailty. Calcif Tissue Int 93(2):101–120.  https://doi.org/10.1007/s00223-013-9758-y Google Scholar
  9. 9.
    Mayhew A, Amog K, Phillips S, Parise G, McNicholas P, de Souza R et al (2018) The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing 48(1):48–56Google Scholar
  10. 10.
    Anker SD, Morley JE, von Haehling S (2016) Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle 7(5):512–514Google Scholar
  11. 11.
    Marzetti E, Calvani R, Tosato M, Cesari M, Di Bari M, Cherubini A et al (2017) Sarcopenia: an overview. Aging Clin Exp Res 29(1):11–17Google Scholar
  12. 12.
    Dent E, Morley J, Cruz-Jentoft A, Arai H, Kritchevsky S, Guralnik J et al (2018) International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging 22(10):1148–1161Google Scholar
  13. 13.
    Chindapasirt J (2015) Sarcopenia in cancer patients. Asian Pac J Cancer Prev APJCP 16(18):8075–8077Google Scholar
  14. 14.
    von Haehling S (2018) Muscle wasting and sarcopenia in heart failure: a brief overview of the current literature. ESC Heart Fail 5(6):1074–1082.  https://doi.org/10.1002/ehf2.12388 Google Scholar
  15. 15.
    Jones SE, Maddocks M, Kon SS, Canavan JL, Nolan CM, Clark AL et al (2015) Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax 70(3):213–218.  https://doi.org/10.1136/thoraxjnl-2014-206440 Google Scholar
  16. 16.
    Shenkin SD, Harrison JK, Wilkinson T, Dodds RM, Ioannidis JP (2017) Systematic reviews: guidance relevant for studies of older people. Age Ageing 46(5):722–728Google Scholar
  17. 17.
    Ioannidis JP (2009) Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ 181(8):488–493.  https://doi.org/10.1503/cmaj.081086 Google Scholar
  18. 18.
    Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–423.  https://doi.org/10.1093/ageing/afq034 Google Scholar
  19. 19.
    Chen L-K, Liu L-K, Woo J, Assantachai P, Auyeung T-W, Bahyah KS et al (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15(2):95–101Google Scholar
  20. 20.
    Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C et al (2007) Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 7(1):10.  https://doi.org/10.1186/1471-2288-7-10 Google Scholar
  21. 21.
    Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820–826Google Scholar
  22. 22.
    Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB et al (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol Ser A Biomed Sci Med Sci 69(5):547–558Google Scholar
  23. 23.
    Higgins JP, Thompson SG, Spiegelhalter DJ (2009) A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 172(1):137–159.  https://doi.org/10.1111/j.1467-985X.2008.00552.x Google Scholar
  24. 24.
    Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558.  https://doi.org/10.1002/sim.1186 Google Scholar
  25. 25.
    Ioannidis JP, Patsopoulos NA, Evangelou E (2007) Uncertainty in heterogeneity estimates in meta-analyses. BMJ 335(7626):914–916.  https://doi.org/10.1136/bmj.39343.408449.80 Google Scholar
  26. 26.
    Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634Google Scholar
  27. 27.
    Carvalho AF, Kohler CA, Brunoni AR, Miskowiak KW, Herrmann N, Lanctot KL et al (2016) Bias in peripheral depression biomarkers. Psychother Psychosom 85(2):81–90.  https://doi.org/10.1159/000441457 Google Scholar
  28. 28.
    Ioannidis JP, Trikalinos TA (2007) An exploratory test for an excess of significant findings. Clin Trials 4(3):245–253.  https://doi.org/10.1177/1740774507079441 Google Scholar
  29. 29.
    Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P (2015) Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Healthc 13(3):132–140.  https://doi.org/10.1097/xeb.0000000000000055 Google Scholar
  30. 30.
    Belbasis L, Savvidou MD, Kanu C, Evangelou E, Tzoulaki I (2016) Birth weight in relation to health and disease in later life: an umbrella review of systematic reviews and meta-analyses. BMC Med 14(1):147.  https://doi.org/10.1186/s12916-016-0692-5 Google Scholar
  31. 31.
    Bellou V, Belbasis L, Tzoulaki I, Evangelou E, Ioannidis JP (2016) Environmental risk factors and Parkinson’s disease: an umbrella review of meta-analyses. Parkinsonism Related Disord 23:1–9.  https://doi.org/10.1016/j.parkreldis.2015.12.008 Google Scholar
  32. 32.
    Dinu M, Pagliai G, Casini A, Sofi F (2017) Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomized trials. Nutr Metabol Cardiovasc Dis 27(1):e21.  https://doi.org/10.1016/j.numecd.2016.11.055 Google Scholar
  33. 33.
    Kyrgiou M, Kalliala I, Markozannes G, Gunter MJ, Paraskevaidis E, Gabra H et al (2017) Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ 356(28):j477.  https://doi.org/10.1136/bmj.j477 Google Scholar
  34. 34.
    Li X, Meng X, Timofeeva M, Tzoulaki I, Tsilidis KK, Ioannidis PA et al (2017) Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies. BMJ 357:j2376Google Scholar
  35. 35.
    Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JPA (2014) Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ Br Med J 348:g2035Google Scholar
  36. 36.
    Veronese N, Solmi M, Caruso MG, Giannelli G, Osella AR, Evangelou E et al (2018) Dietary fiber and health outcomes: an umbrella review of systematic reviews and meta-analyses. Am J Clin Nutr 107(3):436–444.  https://doi.org/10.1093/ajcn/nqx082 Google Scholar
  37. 37.
    Zhang X, Huang P, Dou Q, Wang C, Zhang W, Yang Y et al (2019) Falls among older adults with sarcopenia dwelling in nursing home or community: a meta-analysis. Clin Nutr (Edinb Scotl) 25:25.  https://doi.org/10.1016/j.clnu.2019.01.002 Google Scholar
  38. 38.
    Zhang Y, Hao Q, Ge M, Dong B (2018) Association of sarcopenia and fractures in community-dwelling older adults: a systematic review and meta-analysis of cohort studies. Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 29(6):1253–1262.  https://doi.org/10.1007/s00198-018-4429-5 Google Scholar
  39. 39.
    Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyere O (2017) Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One 12(1):e0169548.  https://doi.org/10.1371/journal.pone.0169548 Google Scholar
  40. 40.
    Zhao Y, Zhang Y, Hao Q, Ge M, Dong B (2019) Sarcopenia and hospital-related outcomes in the old people: a systematic review and meta-analysis. Aging Clin Exp Res 31(1):5–14.  https://doi.org/10.1007/s40520-018-0931-z Google Scholar
  41. 41.
    Yang Z, Zhou X, Ma B, Xing Y, Jiang X, Wang Z (2018) Predictive value of preoperative sarcopenia in patients with gastric cancer: a meta-analysis and systematic review. J Gastrointest Surg Off J Soc Surg Aliment Tract 22(11):1890–1902.  https://doi.org/10.1007/s11605-018-3856-0 Google Scholar
  42. 42.
    Zhang X, Wang C, Dou Q, Zhang W, Yang Y, Xie X (2018) Sarcopenia as a predictor of all-cause mortality among older nursing home residents: a systematic review and meta-analysis. BMJ Open 8(11):e021252.  https://doi.org/10.1136/bmjopen-2017-021252 Google Scholar
  43. 43.
    Sayer AA (2014) Sarcopenia the new geriatric giant: time to translate research findings into clinical practice. Br Geriatr Soc 43(6):736–737Google Scholar
  44. 44.
    Beaudart C, Rolland Y, Cruz-Jentoft A, Bauer J, Sieber C, Cooper C et al (2019) Assessment of Muscle Function and Physical Performance in Daily Clinical Practice: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Calcif Tissue Int.  https://doi.org/10.1007/s00223-019-00545-w Google Scholar
  45. 45.
    Cruz-Jentoft AJ, Sayer AA (2019) Sarcopenia. Lancet 393(10191):2636–2646.  https://doi.org/10.1016/S0140-6736(19)31138-9 Google Scholar
  46. 46.
    Calvani R, Marini F, Cesari M, Tosato M, Anker SD, Von Haehling S et al (2015) Biomarkers for physical frailty and sarcopenia: state of the science and future developments. J Cachexia Sarcopenia Muscle 6(4):278–286.  https://doi.org/10.1002/jcsm.12051 Google Scholar
  47. 47.
    Cruz-Jentoft AJ, Kiesswetter E, Drey M, Sieber CC (2017) Nutrition, frailty, and sarcopenia. Aging Clin Exp Res 29(1):43–48Google Scholar
  48. 48.
    Bano G, Trevisan C, Carraro S, Solmi M, Luchini C, Stubbs B et al (2017) Inflammation and sarcopenia: a systematic review and meta-analysis. Maturitas 96:10–15.  https://doi.org/10.1016/j.maturitas.2016.11.006 Google Scholar
  49. 49.
    Can B, Kara O, Kizilarslanoglu MC, Arik G, Aycicek GS, Sumer F et al (2017) Serum markers of inflammation and oxidative stress in sarcopenia. Aging Clin Exp Res 29(4):745–752Google Scholar
  50. 50.
    Dunn JE, Rudberg MA, Furner SE, Cassel CK (1992) Mortality, disability, and falls in older persons: the role of underlying disease and disability. Am J Public Health 82(3):395–400Google Scholar
  51. 51.
    Du Y, Karvellas CJ, Baracos V, Williams DC, Khadaroo RG, Group ESA (2014) Sarcopenia is a predictor of outcomes in very elderly patients undergoing emergency surgery. Surgery 156(3):521–527Google Scholar
  52. 52.
    Anker MS, Von Haehling S, Springer J, Banach M, Anker SD (2013) Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. Int J Cardiol 162(2):73–76Google Scholar
  53. 53.
    Joglekar S, Nau PN, Mezhir JJ (2015) The impact of sarcopenia on survival and complications in surgical oncology: a review of the current literature. J Surg Oncol 112(5):503–509Google Scholar
  54. 54.
    Ioannidis JP, Patsopoulos NA, Rothstein HR (2008) Reasons or excuses for avoiding meta-analysis in forest plots. BMJ 336(7658):1413–1415.  https://doi.org/10.1136/bmj.a117 Google Scholar

Copyright information

© European Geriatric Medicine Society 2019

Authors and Affiliations

  • Nicola Veronese
    • 1
    Email author
  • Jacopo Demurtas
    • 2
  • Pinar Soysal
    • 3
  • Lee Smith
    • 4
  • Gabriel Torbahn
    • 5
  • Daniel Schoene
    • 6
  • Lukas Schwingshackl
    • 7
  • Cornel Sieber
    • 5
    • 8
  • Jurgen Bauer
    • 9
  • Matteo Cesari
    • 10
  • Oliviere Bruyere
    • 11
  • Jean-Yves Reginster
    • 11
  • Charlotte Beaudart
    • 11
  • Alfonso J. Cruz-Jentoft
    • 12
  • Cyrus Cooper
    • 13
    • 14
  • Mirko Petrovic
    • 15
  • Stefania Maggi
    • 1
  • the Special Interest Groups in Systematic Reviews and Meta-analyses for healthy ageing Sarcopenia and Frailty and resilience in older persons of the European Geriatric Medicine Society (EuGMS)
  1. 1.National Research Council, Neuroscience InstitutePaduaItaly
  2. 2.Primary Care Department AziendaUSL Toscana Sud EstGrossetoItaly
  3. 3.Department of Geriatric MedicineBezmialem Vakif UniversityIstanbulTurkey
  4. 4.The Cambridge Centre for Sport and Exercise SciencesAnglia Ruskin UniversityCambridgeUK
  5. 5.Institute for Biomedicine of AgingFriedrich-Alexander-Universität Erlangen-NürnbergNurembergGermany
  6. 6.Institute of Medical PhysicsFriedrich-Alexander-Universität Erlangen-NürnbergErlangenGermany
  7. 7.Institute for Evidence in Medicine (for Cochrane Germany Foundation), Medical CenterUniversity of FreiburgFreiburgGermany
  8. 8.Kantonsspital WinterthurWinterthurSwitzerland
  9. 9.Center for Geriatric MedicineUniversity of Heidelberg, Agaplesion Bethanien HospitalHeidelbergGermany
  10. 10.Geriatric Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore PoliclinicoUniversity of MilanMilanItaly
  11. 11.WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging, Division of Public Health, Epidemiology and Health EconomicsUniversity of LiègeLiègeBelgium
  12. 12.Servicio de Geriatría, Hospital Universitario Ramón y Cajal (IRYCIS)MadridSpain
  13. 13.MRC Life Course Epidemiology UnitUniversity of Southampton, Southampton General HospitalSouthamptonUK
  14. 14.NIHR Musculoskeletal Biomedical Research UnitUniversity of OxfordOxfordUK
  15. 15.Department of GeriatricsGhent University HospitalGhentBelgium

Personalised recommendations